Hikma Pharmaceutical | HIK - Cost Of Sales

Hikma Pharmaceutical reported $662M in Cost of Sales for its second fiscal semester of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cost Of Sales Change
Artemis Alpha ATS:LN GBP 507K 125K
AstraZeneca AZN:LN USD 2.51B 393M
Bayer BAYN:GR EUR 4.77B 521M
Fresenius FRE:GR EUR 7.86B 105M
Fresenius Medical Care FMS:US EUR 3.65B 88.58M
GlaxoSmithKline GSK:LN GBP 2.18B 209M
Hikma Pharmaceutical HIK:LN USD 662M 72M
Merck MRK:GR EUR 2.28B 137M
Orion ORNBV:FH EUR 139.3M 3.2M
Recordati REC:IM EUR 154.92M 2.52M
Roche Holding ROG:VX 8.95B 613M